Compare ARVN & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARVN | BBW |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 696.0M |
| IPO Year | 2018 | 2004 |
| Metric | ARVN | BBW |
|---|---|---|
| Price | $13.48 | $55.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 7 |
| Target Price | $18.14 | ★ $67.71 |
| AVG Volume (30 Days) | ★ 753.9K | 297.6K |
| Earning Date | 02-11-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 1.62% |
| EPS Growth | N/A | ★ 15.02 |
| EPS | N/A | ★ 4.36 |
| Revenue | $312,300,000.00 | ★ $525,767,000.00 |
| Revenue This Year | $10.55 | $8.05 |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $12.48 |
| Revenue Growth | ★ 93.86 | 6.17 |
| 52 Week Low | $5.90 | $32.55 |
| 52 Week High | $20.38 | $75.85 |
| Indicator | ARVN | BBW |
|---|---|---|
| Relative Strength Index (RSI) | 57.38 | 34.14 |
| Support Level | $12.88 | $54.08 |
| Resistance Level | $14.14 | $61.82 |
| Average True Range (ATR) | 0.70 | 2.46 |
| MACD | 0.02 | -1.34 |
| Stochastic Oscillator | 67.89 | 7.00 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.